1. Home
  2. ECG vs MIRM Comparison

ECG vs MIRM Comparison

Compare ECG & MIRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ECG
  • MIRM
  • Stock Information
  • Founded
  • ECG 1995
  • MIRM 2018
  • Country
  • ECG United States
  • MIRM United States
  • Employees
  • ECG N/A
  • MIRM N/A
  • Industry
  • ECG
  • MIRM Biotechnology: Pharmaceutical Preparations
  • Sector
  • ECG
  • MIRM Health Care
  • Exchange
  • ECG NYSE
  • MIRM Nasdaq
  • Market Cap
  • ECG 1.9B
  • MIRM 1.9B
  • IPO Year
  • ECG N/A
  • MIRM 2019
  • Fundamental
  • Price
  • ECG $38.85
  • MIRM $39.10
  • Analyst Decision
  • ECG Strong Buy
  • MIRM Strong Buy
  • Analyst Count
  • ECG 2
  • MIRM 11
  • Target Price
  • ECG $67.50
  • MIRM $58.55
  • AVG Volume (30 Days)
  • ECG 816.9K
  • MIRM 476.2K
  • Earning Date
  • ECG 05-15-2025
  • MIRM 05-07-2025
  • Dividend Yield
  • ECG N/A
  • MIRM N/A
  • EPS Growth
  • ECG 4.46
  • MIRM N/A
  • EPS
  • ECG 2.81
  • MIRM N/A
  • Revenue
  • ECG $2,849,685,000.00
  • MIRM $336,888,000.00
  • Revenue This Year
  • ECG $8.01
  • MIRM $29.51
  • Revenue Next Year
  • ECG $6.60
  • MIRM $20.27
  • P/E Ratio
  • ECG $13.83
  • MIRM N/A
  • Revenue Growth
  • ECG N/A
  • MIRM 80.76
  • 52 Week Low
  • ECG $31.38
  • MIRM $23.14
  • 52 Week High
  • ECG $77.93
  • MIRM $54.23
  • Technical
  • Relative Strength Index (RSI)
  • ECG N/A
  • MIRM 34.64
  • Support Level
  • ECG N/A
  • MIRM $37.83
  • Resistance Level
  • ECG N/A
  • MIRM $40.32
  • Average True Range (ATR)
  • ECG 0.00
  • MIRM 2.47
  • MACD
  • ECG 0.00
  • MIRM -0.33
  • Stochastic Oscillator
  • ECG 0.00
  • MIRM 25.14

About ECG EVERUS CONSTRUCTION GROUP INC

Everus Construction Group Inc is a construction solutions provider, offering specialty contracting services to a diverse set of end markets across the U.S. It operates across two segments Electrical & Mechanical (E&M) and Transmission & Distribution (T&D), and delivers services through its subsidiaries. It generates the majority of revenue from the Electrical & Mechanical segment which offers a wide variety of specialty contracting services, including construction and maintenance of electrical and communication wiring, fire suppression systems, and mechanical piping and services, to customers in both the public and private sectors. Its T&D segment serves electric and natural gas utility customers, as well as customers in the transportation end market, in the West and Midwest regions.

About MIRM Mirum Pharmaceuticals Inc.

Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of novel therapies for debilitating rare and orphan diseases. Its product, Livmarli, a novel, orally administered, minimally-absorbed ileal bile acid transporter IBAT) inhibitor (IBATi), is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS). It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC, and Alagille syndrome, or ALGS. The company is also involved in the development of volixibat for the treatment of adult patients with cholestatic liver diseases.

Share on Social Networks: